The poster presentations, delivered by several of Imbed’s clinical collaborators, will highlight results in a variety of complex, chronic wounds and surgical applications. The clinical case series were conducted independently at Mount Sinai Hospital (New York), Temple University School of Podiatric Medicine (Philadelphia), the Institute for Advanced Wound Care (Montgomery, AL), and St. Vincent Health (Billings, MT) and typically evaluated wound closure after application of Microlyte® Matrix to leg ulcers, surgical wounds in diabetic patients, and various chronic colonized wounds. The cases conducted at Mount Sinai involved the use of Microlyte® Matrix under a biologic graft material.
“This set of research posters is the latest demonstration of what Microlyte® Matrix can do in aiding healing in both acute and chronic wounds. We are grateful to the world-class clinical partners that have embrace this new an exciting product in the treatment of their patients,” said Jeff Dalsin, PhD, Imbed’s Vice President of Products. “We hear every day how Microlyte® Matrix is changing people’s lives. That makes our work exceptionally gratifying.”
SAWC poster presentations featuring Microlyte® Matrix during the SAWC Poster Gala from 5:15 to 6:15pm on October 13 will include: